The article reports that Singapore-based MerLion Pharmaceuticals acquired Berlin, Germany-based Combinature Biopharm and Geneva, Switzerland-based Athelas on August 2006. This marks the growing maturity of the biotechnology industry in Asia and of the ongoing globalization of the industry as a whole. The company was formed in 2002 through the privatization of the Center for Natural Product Research.